Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy?
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin family that provides useful prognostic information and facilitates diagnosti...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | srp |
| Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2022-01-01
|
| Series: | Arhiv za farmaciju |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2022/0004-19632202247V.pdf |